\
&
Contact us
\
&
Contact us
This was 9 months ago
LocationPalais des Académies, Brussels
The Informal Group of RTD Liaison Offices in Brussels (IGLO) is organising its annual summer reception on Wednesday 2 July 2025 from 15:00-18:00 (doors open at 14:30) in Brussels.
Here is the programme:
You can find more details and register here until 24 June 2025.
IGLO is an informal association of Brussels-based non-profit research and development liaison offices. It aims to facilitate and enhance interaction, information exchange and cooperation between IGLO members (such as NCP Flanders), national research systems and European institutions related to EU RTD.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
